Correlation Between Allogene Therapeutics and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Allogene Therapeutics and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allogene Therapeutics and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Allogene Therapeutics and Akero Therapeutics, you can compare the effects of market volatilities on Allogene Therapeutics and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allogene Therapeutics with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allogene Therapeutics and Akero Therapeutics.
Diversification Opportunities for Allogene Therapeutics and Akero Therapeutics
0.12 | Correlation Coefficient |
Average diversification
The 3 months correlation between Allogene and Akero is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Allogene Therapeutics and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Allogene Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allogene Therapeutics are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Allogene Therapeutics i.e., Allogene Therapeutics and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Allogene Therapeutics and Akero Therapeutics
Given the investment horizon of 90 days Allogene Therapeutics is expected to under-perform the Akero Therapeutics. In addition to that, Allogene Therapeutics is 1.49 times more volatile than Akero Therapeutics. It trades about -0.06 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.02 per unit of volatility. If you would invest 3,052 in Akero Therapeutics on September 1, 2024 and sell it today you would earn a total of 158.00 from holding Akero Therapeutics or generate 5.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Allogene Therapeutics vs. Akero Therapeutics
Performance |
| Timeline |
| Allogene Therapeutics |
| Akero Therapeutics |
Allogene Therapeutics and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Allogene Therapeutics and Akero Therapeutics
The main advantage of trading using opposite Allogene Therapeutics and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allogene Therapeutics position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Allogene Therapeutics vs. Heron Therapeuti | Allogene Therapeutics vs. Annexon | Allogene Therapeutics vs. Sangamo Therapeutics | Allogene Therapeutics vs. Beam Therapeutics |
| Akero Therapeutics vs. Tff Pharmaceuticals | Akero Therapeutics vs. Eliem Therapeutics | Akero Therapeutics vs. Inhibrx | Akero Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |